TDOC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Teladoc Health, Inc. Investors With Substantial Losses Have Opportunity To Lead Class Action Lawsuit!

( MENAFN - GlobeNewsWire - Nasdaq) NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Teladoc Health, Inc. (“Teladoc” or“the Company”) (NYSE: TDOC) and certain of its officers. Class Definition: This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Teladoc securities between November 2, 2022 and February 20, 2024, inclusive (the“Class Period”).

Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/TDOC . Case Details: The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose material adverse information regarding the Company, including allegations that: (1) Teladoc continued to expand its marketing spend throughout 2023, despite public assurances that it would pull back its advertising spending; (2) increased marketing spend on BetterHelp deteriorated Teladoc's revenue, with little return for that investment; (3) despite Teladoc's acknowledgment that increased advertising spend would be marginally inefficient due to market saturation, it continued to grow its advertising spend in the BetterHelp business; and (4) despite public statements that there remained“a long.